Xanthine oxidase inhibition reduces reactive nitrogen species production in COPD airways
Authors:
- M. IchinoseMIM. Ichinose
- H. SugiuraHSH. Sugiura
- S. YamagataSYS. Yamagata
- A. KoaraiAKA. Koarai
- M. TomakiMTM. Tomaki
- H. OgawaHOH. Ogawa
- Y. KomakiYKY. Komaki
- P.J. BarnesP.J. Barnes
- K. ShiratoKSK. Shirato
- T. HattoriTHT. Hattori
- 1 September 2003
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 22 (3) , 457-461
Abstract
Reactive nitrogen species (RNS) have been reported to be involved in the inflammatory process in chronic obstructive pulmonary disease (COPD). However, there are no studies on the modulation of RNS in COPD. It was hypothesised that inhibition of xanthine oxidase (XO) might decrease RNS production in COPD airways through the suppression of superoxide anion production.Ten COPD and six healthy subjects participated in the study. The XO inhibitor allopurinol (300 mg·day−1p.o.for 4 weeks) was administered to COPD patients. RNS production in the airway was assessed by 3‐nitrotyrosine immunoreactivity and enzymic activity of XO in induced sputum as well as by exhaled nitric oxide (eNO) concentration.XO activity in the airway was significantly elevated in COPD compared with healthy subjects. Allopurinol administration to COPD subjects significantly decreased XO activity and nitrotyrosine formation. In contrast, eNO concentration was significantly increased by allopurinol administration.These results suggest that oral administration of the xanthine oxidase inhibitor allopurinol reduces airway reactive nitrogen species production in chronic obstructive pulmonary disease subjects. This intervention may be useful in the future management of chronic obstructive pulmonary disease.Keywords
This publication has 27 references indexed in Scilit:
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Oxidative Stress in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Evidence-Based Health Policy—Lessons from the Global Burden of Disease StudyScience, 1996
- Systemic Oxidative Stress in Asthma, COPD, and SmokersAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Oxidative Damage and Tyrosine Nitration from PeroxynitriteChemical Research in Toxicology, 1996
- Xanthine oxidase activity in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary diseaseFree Radical Biology and Medicine, 1996
- Effect of Smoking Cessation on Airway Inflammation in Chronic BronchitisAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Increased nitric oxide in exhaled air of asthmatic patientsThe Lancet, 1994
- Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.Proceedings of the National Academy of Sciences, 1990
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987